FDA Gives Voxelotor Accelerated Approval for Kids with Sickle cell disease (SCD)
The U.S. Food and Drug Administration (FDA) has granted accelerated approval of a supplemental New Drug Application (sNDA) for Oxbryta® (voxelotor) tablets for the treatment of Sickle cell disease (SC ...
Verismo Therapeutics Receives Fast Track Designation from FDA for SynKIR-110, a Novel CAR T Therapy for Mesothelioma Treatment
Verismo Therapeutics, a clinical-stage company specializing in CAR T technology, has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for its innovative drug, SynKIR-11 ...
FDA Approves TUKYSA® for Metastatic HER2-Positive Colorectal Cancer
Seagen Inc. announced FDA accelerated approval of TUKYSA for RAS wild-type, HER2-positive unresectable or metastatic colorectal cancer. It's the first FDA-approved treatment for HER2-positive metastat ...
